A detailed history of Atlantic Edge Private Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Atlantic Edge Private Wealth Management, LLC holds 1,244 shares of LLY stock, worth $989,415. This represents 0.34% of its overall portfolio holdings.

Number of Shares
1,244
Previous 1,258 1.11%
Holding current value
$989,415
Previous $1.14 Billion 3.23%
% of portfolio
0.34%
Previous 0.38%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$772.14 - $960.02 $10,809 - $13,440
-14 Reduced 1.11%
1,244 $1.1 Billion
Q2 2024

Jul 26, 2024

SELL
$724.87 - $909.04 $25,370 - $31,816
-35 Reduced 2.71%
1,258 $1.14 Billion
Q1 2024

May 08, 2024

SELL
$592.2 - $792.28 $59,220 - $79,228
-100 Reduced 7.18%
1,293 $1.01 Billion
Q4 2023

Feb 08, 2024

BUY
$525.19 - $619.13 $731,589 - $862,448
1,393 New
1,393 $812 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Atlantic Edge Private Wealth Management, LLC Portfolio

Follow Atlantic Edge Private Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlantic Edge Private Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlantic Edge Private Wealth Management, LLC with notifications on news.